The transcriptomics market size is estimated to reach $11,397.08 million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.

PORTLAND, OREGON, UNITED STATES, November 21, 2023 /EINPresswire.com/ -- The Transcriptomics Market is experiencing a transformative era in the field of molecular biology and genetic research. This cutting-edge market involves the study of complete sets of RNA transcripts produced by the genome under specific conditions or in a specific cell, providing a comprehensive view of gene expression patterns. The growing demand for personalized medicine, coupled with advancements in high-throughput sequencing technologies, has fueled the expansion of the transcriptomics sector. According to a new report published by Allied Market Research, titled, “Transcriptomics Market by Type, Technology, Application, and End User: Global Opportunity Analysis and Industry Forecast, 2021–2030," the transcriptomics market size was valued at $5,790.51 million in 2020, and is estimated to reach $11,397.08 million by 2030, growing at a CAGR of 7.0% from 2021 to 2030.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐏𝐃𝐅 𝐎𝐟 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭:
https://www.alliedmarketresearch.com/request-sample/2595

Transcriptomics is the study of the transcriptome, the complete sequence of RNA, known as expression profiles. Transcriptomics includes everything related to RNA. It includes their disclosure status, their role, status and termination. Transcriptome analysis is used to study how genes change in different organisms and is instrumental in understanding human disease.

Major market players covered in the report, such as -

Agilent Technologies Inc.
Bio-Rad Laboratories
F-Hoffmann La-Roche
Fluidigm Corporation
General Electric Company
Illuminia Inc.
Merck & Co. Inc
Promega Corporation
QiagenInc
Thermofisher Scientific

Key Benefits for Stakeholders -

• The report provides quantitative analysis of market segments, current trends, strategies and potential of transcriptomics market research to identify potential transcriptomics market opportunities in genetics.
• In-depth analysis of this sector helps identify current market opportunities.
• Market analysis and information related to key drivers, restraints and opportunities are provided. • Porter's Five Forces Analysis identifies the capabilities of buyers and suppliers to enable stakeholders to make profitable business decisions and strengthen the network of buyers.
• The largest countries in each region are listed according to their contribution to the global market.
• Focusing on market players makes benchmarking easier and provides a clear understanding of the current market situation.
• The report includes regional and global transcriptomics market analysis, key players, market segments, application areas and Market growth strategies.

𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐅𝐨𝐫 𝐂𝐮𝐬𝐭𝐨𝐦𝐢𝐳𝐚𝐭𝐢𝐨𝐧:
https://www.alliedmarketresearch.com/request-for-customization/2595

North America is expected to witness highest growth, in terms of revenue, owing to rise in genetic testing, presence of key players, and advancements in healthcare investments. Asia-Pacific was the second largest contributor to the market in 2020, and is expected to register fastest CAGR during the forecast period, owing to increase in incidences of chronic disorders and unmet needs for advanced technologies for transcriptomics. However, lack of skilled professionals restrain the market growth during the forecast period.

TABLE OF CONTENT -

CHAPTER 1 - INTRODUCTION:
1.1. Report description
1.2. Key market segments
1.3. List of key players profiled in the report
1.4. Research methodology
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models

CHAPTER 2 - EXECUTIVE SUMMARY:
2.1. Key findings of the study
2.2. CXO Perspective

CHAPTER 3 - MARKET OVERVIEW:
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. Market Share Analysis/Top Player Positioning
3.4. Porter’s Five Forces Analysis
3.5. Market Dynamics
3.5.1. Drivers
3.5.2. Restraints
3.5.3. Opportunities…
3.6. COVID-19 Impact Analysis on the market

In addition, the increase in R&D investment thanks to genome projects is starting all over the world. The UK launched the GENE Consortium, the first genome sequencing program in Europe, which requires the sequencing of up to 100,000 genomes of cancer patients, rare diseases and their families across 11 genomic clinics. The above-mentioned factors boost the market growth. However, the lack of qualified professionals is hindering the growth of the market. On the other hand, the presence of this uncertain market in emerging economies is expected to provide a profitable growth opportunity for the market.

𝐈𝐧𝐭𝐞𝐫𝐞𝐬𝐭𝐞𝐝 𝐈𝐧 𝐏𝐫𝐨𝐜𝐮𝐫𝐢𝐧𝐠 𝐓𝐡𝐢𝐬 𝐑𝐞𝐩𝐨𝐫𝐭? 𝐕𝐢𝐬𝐢𝐭 𝐇𝐞𝐫𝐞:
https://www.alliedmarketresearch.com/purchase-enquiry/2595

The transcriptomics market is expected to witness a significant growth in the coming years. This market has gained interest of the healthcare and medical sectors owing to increased prevalence of hypertension throughout the globe. Furthermore, the global transcriptomics market is segmented on the basis of product type, end user, and region. leading market players have been introducing various strategies to help enterprises move their on-premise models to on-demand models.

Frequently Asked Questions?

Q1. What is the total market value of transcriptomics market report?

Q2. Which are the top companies holding the market share in transcriptomics market?

Q3. Which are the largest regions for this Market?

Q4. What is the leading technology of transcriptomics market?

Q5. What are the major drivers for this specific Market?

Q6. What are the upcoming key trends in the transcriptomics market report?

About Us -

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various research data tables and confirms utmost accuracy in our market forecasting. Each and every us companies and this helps us in digging out market data that helps us generate accurate y data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

David Correa
Allied Analytics LLP
+ +1 800-792-5285
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.